2022 Q3 Form 10-Q Financial Statement

#000155485522000457 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.845M $6.475M $808.8K
YoY Change 279.07% 1407.78% 114.44%
% of Gross Profit
Research & Development $14.30M $9.836M $9.115M
YoY Change 409.59% 407.31% 382.26%
% of Gross Profit
Depreciation & Amortization $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
% of Gross Profit
Operating Expenses $21.14M $16.31M $9.923M
YoY Change 1070.92% 588.73% 2531.17%
Operating Profit -$38.57M -$16.35M -$10.43M
YoY Change 929.84% 590.3% 2666.19%
Interest Expense $2.314M $4.710M $444.9K
YoY Change -76.44% 529.51% -96.33%
% of Operating Profit
Other Income/Expense, Net $536.6K -$13.77K -$22.22K
YoY Change
Pretax Income -$36.25M -$11.65M -$9.501M
YoY Change -552.2% 382.56% -180.88%
Income Tax $490.4K $129.7K $0.00
% Of Pretax Income
Net Earnings -$36.74M -$11.78M -$9.501M
YoY Change -558.32% 387.93% 328.52%
Net Earnings / Revenue
Basic Earnings Per Share -$0.14 -$0.43 -$0.05
Diluted Earnings Per Share -$0.14 -$47.32K -$39.29K
COMMON SHARES
Basic Shares Outstanding 264.3M shares 249.0M shares 220.0M shares
Diluted Shares Outstanding 272.0M shares 249.0M shares 220.0M shares

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $248.3M $330.8M $24.68K
YoY Change 23009.93% 24688.57% -98.36%
Cash & Equivalents $77.94M $176.3M $12.51M
Short-Term Investments $170.4M $154.5M
Other Short-Term Assets $2.974M $166.1K $84.90K
YoY Change 1874.95% -23.82% -70.61%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $333.1M $331.2M $109.6K
YoY Change 27092.49% 21234.55% -93.89%
LONG-TERM ASSETS
Property, Plant & Equipment $418.7K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $236.9M
YoY Change 2.0%
Other Assets
YoY Change
Total Long-Term Assets $418.7K $0.00 $236.9M
YoY Change -99.82% -100.0% 2.0%
TOTAL ASSETS
Total Short-Term Assets $333.1M $331.2M $109.6K
Total Long-Term Assets $418.7K $0.00 $236.9M
Total Assets $333.5M $331.2M $237.1M
YoY Change 41.42% 40.24% 1.26%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.963M $889.6K $5.709M
YoY Change -27.2% 2268.55%
Accrued Expenses $972.6K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $150.0K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $28.02M $19.88M $5.859M
YoY Change 588.35% 666.9% 2330.76%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $838.8K $542.8K $24.67M
YoY Change -96.95% -98.55% -31.44%
Total Long-Term Liabilities $838.8K $542.8K $24.67M
YoY Change -96.95% -98.55% -31.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $28.02M $19.88M $5.859M
Total Long-Term Liabilities $838.8K $542.8K $24.67M
Total Liabilities $28.86M $20.42M $30.53M
YoY Change -8.66% -48.86% -15.73%
SHAREHOLDERS EQUITY
Retained Earnings -$197.0M -$9.776M
YoY Change
Common Stock $501.6M $320.6M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $304.7M $310.8M $3.645M
YoY Change
Total Liabilities & Shareholders Equity $333.5M $331.2M $237.1M
YoY Change 41.42% 40.24% 1.26%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$36.74M -$11.78M -$9.501M
YoY Change -558.32% 387.93% 328.52%
Depreciation, Depletion And Amortization $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Operating Activities -$16.96M -$12.58M -$600.7K
YoY Change 6421.97% 7347.85% 28.22%
INVESTING ACTIVITIES
Capital Expenditures -$418.7K $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$96.00M -$154.0M
YoY Change 6595.65%
Cash From Investing Activities -$96.42M -$154.0M $0.00
YoY Change 6595.65%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 15.00M 329.0M 150.0K
YoY Change 14203.21% -94.81%
NET CHANGE
Cash From Operating Activities -16.96M -12.58M -600.7K
Cash From Investing Activities -96.42M -154.0M $0.00
Cash From Financing Activities 15.00M 329.0M 150.0K
Net Change In Cash -98.38M 162.4M -450.7K
YoY Change 37738.06% -96217.6% -3.8%
FREE CASH FLOW
Cash From Operating Activities -$16.96M -$12.58M -$600.7K
Capital Expenditures -$418.7K $0.00
Free Cash Flow -$16.54M -$600.7K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
0 usd
dei Entity Registrant Name
EntityRegistrantName
EVE HOLDING, INC.
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21140 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
331203936 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-2549808
dei Entity Address Address Line1
EntityAddressAddressLine1
1400 General Aviation Drive
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14617663 usd
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
CY2022Q2 us-gaap Assets
Assets
331203936 usd
CY2021Q4 us-gaap Assets
Assets
15317416 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
889594 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
877641 usd
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
9560773 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
7267500 usd
dei Entity Address City Or Town
EntityAddressCityOrTown
Melbourne
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9776431 usd
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
32935
dei City Area Code
CityAreaCode
(321)
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32226 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2159603 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
19877470 usd
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39704
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Central Index Key
EntityCentralIndexKey
0001823652
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Type
DocumentType
10-Q
dei Local Phone Number
LocalPhoneNumber
751-5050
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
264332132 shares
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1526023 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32226 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
310783657 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13088472 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
176316554 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2022Q2 us-gaap Short Term Investments
ShortTermInvestments
154464652 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
331203936 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15317416 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1938812 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18950423 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3830463 usd
CY2022Q2 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
256645 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6475430 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
429467 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
220000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
166085 usd
CY2022Q2 us-gaap Liabilities
Liabilities
20420279 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2228944 usd
CY2022Q2 evex Net Parent Investment
NetParentInvestment
0 usd
CY2021Q4 evex Net Parent Investment
NetParentInvestment
13120698 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
320295756 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11781618 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2414626 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
264332132 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264332132 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
235582132 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
235582132 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
264332 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
0 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7284196 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
757410 usd
CY2022Q2 us-gaap Other General Expense
OtherGeneralExpense
37123 usd
CY2021Q2 us-gaap Other General Expense
OtherGeneralExpense
0 usd
us-gaap Other General Expense
OtherGeneralExpense
37123 usd
us-gaap Other General Expense
OtherGeneralExpense
0 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16348289 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2368279 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-26271742 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4587873 usd
CY2022Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4132525 usd
CY2021Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
4132525 usd
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
0 usd
CY2022Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
563854 usd
CY2021Q2 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-46347 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
986566 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-43873 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11651910 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2414626 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21152651 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4631746 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
129708 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
129708 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
248989790 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1013853 usd
us-gaap Net Income Loss
NetIncomeLoss
-21282359 usd
us-gaap Net Income Loss
NetIncomeLoss
-4631746 usd
CY2022Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
234574977 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220000000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2414626 usd
us-gaap Net Income Loss
NetIncomeLoss
-21282359 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
50195 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
0 usd
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-911 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-11781618 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2364431 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4632657 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13088472 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-9500741 usd
CY2022Q1 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
732776 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
3644887 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11781618 usd
CY2022Q2 evex Increase Decrease Through Reclassification Of Public Warrants From Liability To Equity
IncreaseDecreaseThroughReclassificationOfPublicWarrantsFromLiabilityToEquity
9200000 usd
CY2022Q2 evex Stock Issued During Period Value Reverse Recapitalization Net Of Fees
StockIssuedDuringPeriodValueReverseRecapitalizationNetOfFees
308472363 usd
CY2022Q2 evex Stock Issued During Period Value Restricted Stock Units Vested
StockIssuedDuringPeriodValueRestrictedStockUnitsVested
1028369 usd
evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
219656 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
310783657 usd
CY2021Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-51106 usd
CY2021Q1 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
3004907 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-277172 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2414626 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-911 usd
CY2021Q2 evex Increase Decrease Through Net Transfer From Parent Equity
IncreaseDecreaseThroughNetTransferFromParentEquity
2283398 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-409311 usd
us-gaap Net Income Loss
NetIncomeLoss
-21282359 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
0 usd
us-gaap Capitalized Computer Software Amortization1
CapitalizedComputerSoftwareAmortization1
54063 usd
evex Long Term Incentive Plan Expense Income
LongTermIncentivePlanExpenseIncome
-252729 usd
evex Long Term Incentive Plan Expense Income
LongTermIncentivePlanExpenseIncome
96693 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
952432 usd
us-gaap Other Noncash Expense
OtherNoncashExpense
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1028369 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4132500 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 usd
evex Interest Income On Financial Investments
InterestIncomeOnFinancialInvestments
464652 usd
evex Interest Income On Financial Investments
InterestIncomeOnFinancialInvestments
0 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
153512 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11674 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-216083 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
0 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
730186 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-680694 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9835736 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
9560773 usd
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1938812 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
614107 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18950423 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
117550 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13183802 usd
us-gaap Contribution Of Property
ContributionOfProperty
0 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3830463 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-16348289 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
9560773 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5055808 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
154000000 usd
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-154000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
0 usd
us-gaap Proceeds From Contributions From Parent
ProceedsFromContributionsFromParent
5055808 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
377009090 usd
us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
0 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
47885258 usd
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
329123832 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5055808 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
161940030 usd
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14376523 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
176316554 usd
us-gaap Contribution Of Property
ContributionOfProperty
232496 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
220000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21140 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
14617663 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
CY2021Q4 us-gaap Assets
Assets
15317416 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
877641 usd
CY2021Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
32226 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1526023 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2228944 usd
CY2021Q4 evex Net Parent Investment
NetParentInvestment
13120698 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-32226 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
13088472 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
15317416 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2368279 usd
CY2021Q4 us-gaap Due From Related Parties
DueFromRelatedParties
220000 usd
evex Monetary And Foreign Exchange Variations On Trade Accounts Receivable And Contract Assets
MonetaryAndForeignExchangeVariationsOnTradeAccountsReceivableAndContractAssets
-299 usd
evex Monetary And Foreign Exchange Variations On Trade Accounts Receivable And Contract Assets
MonetaryAndForeignExchangeVariationsOnTradeAccountsReceivableAndContractAssets
0 usd
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Tax Credits
MonetaryAndForeignExchangeVariationsOnTaxCredits
-3073 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Tax Credits
MonetaryAndForeignExchangeVariationsOnTaxCredits
0 usd
us-gaap Derivatives Methods Of Accounting Hedge Documentation
DerivativesMethodsOfAccountingHedgeDocumentation
<p style="font-size: 10pt; line-height: 1.2; margin: 0px; text-align: justify; text-indent: 0px;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Hedge accounting</span></p> <p style="line-height: 10pt; text-align: justify; text-indent: 0px; margin: 0px;"><br/></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Until December 31, 2021, the Company accounted for certain derivative instruments under the cash flow hedge accounting methodology to hedge against the payroll cash flow volatility attributable to a risk of foreign exchange rate fluctuation associated with highly probable forecast transactions that will affect income or loss for the year. Effective January 1, 2022, no hedge transactions were observed since the derivative contracts were not transferred to Eve. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company recognizes all derivative instruments as either assets or liabilities in the balance sheet at their respective fair values. For derivatives designated in hedging relationships changes in the fair value are recognized in Accumulated Other Comprehensive Loss (“AOCI”), to the extent the derivative is effective at offsetting the changes in cash flows being hedged until the hedged item affects earnings. The cash flow impact of the derivative instruments is included in our combined statement of cash flows in net cash used in operating activities. </span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">The Company only enters into derivative contracts that it intends to designate as a hedge of a forecasted transaction or the variability of cash flows to be received or paid related to a recognized asset or liability (cash flow hedge). For all hedging relationships, the Eve formally documents the hedging relationship and its risk-management objective and strategy for undertaking the hedge, the hedging instrument, the hedged transaction, the nature of the risk being hedged, how the hedging instrument’s effectiveness in offsetting the hedged risk will be assessed prospectively and retrospectively, and a description of the method used to measure ineffectiveness. The Company also formally assesses, both at the inception of the hedging relationship and on an ongoing basis, whether the derivatives that are used in hedging relationships are highly effective in offsetting changes in cash flows of hedged transactions. For derivative instruments that are designated and qualify as part of a cash flow hedging relationship, the effective portion of the gain or loss on the derivative is reported as a component of other comprehensive loss and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current earnings. </span></p> <div> <div id="t_ft_46FRHKFJY800000000000000000000b"> </div> </div> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">Eve discontinues hedge accounting prospectively when it determines that the derivative is no longer effective in offsetting cash flows attributable to the hedged risk, the derivative expires or is sold, terminated, or exercised, the cash flow hedge is designated because a forecasted transaction is not probable of occurring, or management determines to remove the designation of the cash flow hedge. Additionally, when it is probable that a forecasted transaction will not occur, Eve recognizes immediately in earnings gains and losses that were accumulated in other comprehensive loss related to the hedging relationship.</span></p> <p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify; text-indent: 18pt;"><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;">In all situations in which hedge accounting is discontinued and the derivative remains outstanding, Eve</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> continues to carry the derivative at its fair value on the balance sheet and recognizes any subsequent changes in its fair value in earnings.</span><span style="font-family: 'Times New Roman'; font-size: 10pt; line-height: inherit;"> </span></p>
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
8492772 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
256645 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
9560773 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size: 10pt; line-height: 1.2; margin: 0pt 0pt 8pt; text-align: justify;"><span style="font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold; line-height: inherit;">Use of Estimates </span></p> <p style="margin: 8pt 0pt; text-align: justify; text-indent: 20pt; line-height: 1.2; font-size: 11pt; font-family: Calibri, sans-serif;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">The preparation of condensed combined consolidated financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and judgments that affected the reported amounts of assets and liabilities and allocations of expenses. These judgments were based on the historical experience, management’s evaluation of trends in the industry and other factors that were deemed relevant at that time. The estimates and assumptions were reviewed on a regular basis and the changes to accounting estimates were recognized in the period in which the estimates were revised. The Company’s management recognize that the actual results could be materially different from the estimates. Until December 31, 2021, under the management approach, the s</span><span style="font-size: 10pt; line-height: inherit; font-family: 'Times New Roman', serif; margin: 8pt 0pt; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; font-family: 'times new roman', times; line-height: inherit;">ignificant estimates inherent in the preparation of the unaudited condensed combined financial statements include, but are not limited to, useful lives of capitalized software, net, accrued liabilities, income taxes including deferred tax assets and liabilities. Under the legal entity approach, the significant estimates include, but are not limited to, fair value measurement and income taxes.</span></span></p>
evex Monetary And Foreign Exchange Variations On Tax Credits
MonetaryAndForeignExchangeVariationsOnTaxCredits
-2308 usd
CY2022Q2 evex Due To Related Parties From Reimbursement For Marketing Expenses
DueToRelatedPartiesFromReimbursementForMarketingExpenses
589852 usd
CY2022Q2 us-gaap Due To Employees Current And Noncurrent
DueToEmployeesCurrentAndNoncurrent
320313 usd
evex Monetary And Foreign Exchange Variations On Tax Credits
MonetaryAndForeignExchangeVariationsOnTaxCredits
0 usd
us-gaap Income Tax Examination Likelihood Of Unfavorable Settlement
IncomeTaxExaminationLikelihoodOfUnfavorableSettlement
greater than 50%
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 pure
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
3 pure
us-gaap Operating Income Loss
OperatingIncomeLoss
-26271742 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4587873 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Assets
MonetaryAndForeignExchangeVariationsOnAssets
-386542 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Assets
MonetaryAndForeignExchangeVariationsOnAssets
0 usd
CY2022Q2 us-gaap Due From Related Parties
DueFromRelatedParties
256645 usd
evex Monetary And Foreign Exchange Variations On Assets
MonetaryAndForeignExchangeVariationsOnAssets
89584 usd
evex Monetary And Foreign Exchange Variations On Assets
MonetaryAndForeignExchangeVariationsOnAssets
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Suppliers
MonetaryAndForeignExchangeVariationsOnSuppliers
-64203 usd
us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<p style="margin: 10pt 0pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1; text-indent: 0pt;"><span style="font-family: 'times new roman', times; line-height: inherit;"><b style="mso-bidi-font-weight: normal;"><span style="font-size: 10pt; color: black; line-height: inherit;">Derivative Financial Instruments</span></b></span></p> <p style="margin: 0cm 0cm 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1;"><span style="font-size: 10pt; line-height: inherit; margin: 8pt 0cm; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; color: #000000; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: 'times new roman', times; line-height: inherit;">       The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives in accordance with ASC Topic 815, “<i>Derivatives and Hedging</i>”. The Company’s derivative instruments are recorded at fair value and re-valued at each reporting date, with changes in the fair value reported in the Statement of Operations. Derivative assets and liabilities are classified on the balance sheet as current or non-current based on whether or not net-cash settlement or conversion of the instrument could be required within 12 months of the balance sheet date.</span></span></p> <p style="margin: 0cm 0cm 0.0001pt; text-align: justify; font-size: 12pt; font-family: 'Times New Roman', serif; line-height: 1;"><span style="font-size: 10pt; line-height: inherit; margin: 8pt 0cm; text-align: justify; text-indent: 20pt;"><span style="font-size: 10pt; color: #000000; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; font-family: 'times new roman', times; line-height: inherit;"><br/></span></span></p>
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
92824351 usd
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
14131396 usd
CY2022Q2 us-gaap Cash And Due From Banks
CashAndDueFromBanks
92824351 usd
CY2021Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
14131396 usd
CY2022Q2 evex Private Securities At Carrying Value
PrivateSecuritiesAtCarryingValue
2363683 usd
CY2021Q4 evex Private Securities At Carrying Value
PrivateSecuritiesAtCarryingValue
245127 usd
CY2022Q2 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
81128520 usd
CY2021Q4 us-gaap Time Deposits At Carrying Value
TimeDepositsAtCarryingValue
0 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
83492203 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
245127 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14376523 usd
CY2022Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
9560773 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
616156 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
542809 usd
CY2022Q2 evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
8492772 usd
CY2021Q2 evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
0 usd
evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
15957006 usd
evex Operating Income Loss Net From Transactions With Related Party
OperatingIncomeLossNetFromTransactionsWithRelatedParty
0 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Suppliers
MonetaryAndForeignExchangeVariationsOnSuppliers
0 usd
evex Monetary And Foreign Exchange Variations On Suppliers
MonetaryAndForeignExchangeVariationsOnSuppliers
-51627 usd
CY2022Q2 evex Advances To Employees
AdvancesToEmployees
129107 usd
CY2021Q4 evex Advances To Employees
AdvancesToEmployees
17063 usd
CY2022Q2 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
36978 usd
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
4077 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
166085 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
21140 usd
CY2020Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
23443 usd
CY2021Q1 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
83164 usd
CY2021Q1 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
106607 usd
CY2021Q2 us-gaap Capitalized Computer Software Additions
CapitalizedComputerSoftwareAdditions
95269 usd
CY2021Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
201876 usd
CY2021Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
699753 usd
us-gaap Capitalized Computer Software Period Increase Decrease
CapitalizedComputerSoftwarePeriodIncreaseDecrease
-699753 usd
CY2022Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
0 usd
CY2022Q2 evex Provision For Profit Sharing Program
ProvisionForProfitSharingProgram
780127 usd
CY2021Q4 evex Provision For Profit Sharing Program
ProvisionForProfitSharingProgram
59855 usd
CY2022Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
696710 usd
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
455392 usd
CY2022Q2 evex Advances From Customers Current
AdvancesFromCustomersCurrent
405000 usd
CY2021Q4 evex Advances From Customers Current
AdvancesFromCustomersCurrent
405000 usd
CY2022Q2 evex Social Charges Payable Current
SocialChargesPayableCurrent
398074 usd
CY2021Q4 evex Social Charges Payable Current
SocialChargesPayableCurrent
163384 usd
CY2022Q2 evex Long Term Incentive Plan
LongTermIncentivePlan
164290 usd
CY2021Q4 evex Long Term Incentive Plan
LongTermIncentivePlan
183041 usd
CY2022Q2 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
129708 usd
CY2021Q4 us-gaap Accrued Income Taxes
AccruedIncomeTaxes
0 usd
CY2022Q2 evex Advanced Payments Related To Service Arrangements
AdvancedPaymentsRelatedToServiceArrangements
128503 usd
CY2021Q4 evex Advanced Payments Related To Service Arrangements
AdvancedPaymentsRelatedToServiceArrangements
52405 usd
CY2022Q2 us-gaap Other Liabilities
OtherLiabilities
2702412 usd
CY2021Q4 us-gaap Other Liabilities
OtherLiabilities
1319077 usd
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2159603 usd
us-gaap Common Stock Voting Rights
CommonStockVotingRights
one vote per share
us-gaap Dividends Common Stock
DividendsCommonStock
0 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702921 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
evex Monetary And Foreign Exchange Variations On Cash And Cash Equivalents And Financial Investments
MonetaryAndForeignExchangeVariationsOnCashAndCashEquivalentsAndFinancialInvestments
0 usd
CY2021Q2 evex Finance Cost Non Operating
FinanceCostNonOperating
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Other Assets
MonetaryAndForeignExchangeVariationsOnOtherAssets
-9783 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Other Assets
MonetaryAndForeignExchangeVariationsOnOtherAssets
0 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
264332132 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
264332132 shares
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
235582132 shares
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
235582132 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
9100000 shares
CY2021Q4 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
32226 usd
CY2021 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax
OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax
0 usd
CY2022Q2 evex Interest Income On Cash And Cash Equivalents And Financial Investments
InterestIncomeOnCashAndCashEquivalentsAndFinancialInvestments
824567 usd
CY2021Q2 evex Interest Income On Cash And Cash Equivalents And Financial Investments
InterestIncomeOnCashAndCashEquivalentsAndFinancialInvestments
0 usd
evex Interest Income On Cash And Cash Equivalents And Financial Investments
InterestIncomeOnCashAndCashEquivalentsAndFinancialInvestments
887948 usd
evex Interest Income On Cash And Cash Equivalents And Financial Investments
InterestIncomeOnCashAndCashEquivalentsAndFinancialInvestments
0 usd
CY2022Q2 evex Taxes On Finance Income
TaxesOnFinanceIncome
7325 usd
CY2021Q2 evex Taxes On Finance Income
TaxesOnFinanceIncome
0 usd
evex Taxes On Finance Income
TaxesOnFinanceIncome
7700 usd
evex Taxes On Finance Income
TaxesOnFinanceIncome
0 usd
CY2022Q2 evex Other Finance Income Non Operating
OtherFinanceIncomeNonOperating
-1829 usd
CY2021Q2 evex Other Finance Income Non Operating
OtherFinanceIncomeNonOperating
0 usd
evex Other Finance Income Non Operating
OtherFinanceIncomeNonOperating
-1793 usd
evex Other Finance Income Non Operating
OtherFinanceIncomeNonOperating
0 usd
CY2022Q2 evex Finance Income Non Operating
FinanceIncomeNonOperating
815413 usd
CY2021Q2 evex Finance Income Non Operating
FinanceIncomeNonOperating
0 usd
evex Finance Income Non Operating
FinanceIncomeNonOperating
878455 usd
evex Finance Income Non Operating
FinanceIncomeNonOperating
0 usd
CY2022Q2 evex Finance Cost Tax On Financial Transactions
FinanceCostTaxOnFinancialTransactions
3496 usd
CY2021Q2 evex Finance Cost Tax On Financial Transactions
FinanceCostTaxOnFinancialTransactions
0 usd
evex Finance Cost Tax On Financial Transactions
FinanceCostTaxOnFinancialTransactions
24668 usd
evex Finance Cost Tax On Financial Transactions
FinanceCostTaxOnFinancialTransactions
0 usd
CY2022Q2 evex Other Finance Cost Non Operating
OtherFinanceCostNonOperating
839 usd
CY2021Q2 evex Other Finance Cost Non Operating
OtherFinanceCostNonOperating
0 usd
evex Other Finance Cost Non Operating
OtherFinanceCostNonOperating
1056 usd
evex Other Finance Cost Non Operating
OtherFinanceCostNonOperating
0 usd
CY2022Q2 evex Finance Cost On Bank Charges
FinanceCostOnBankCharges
279 usd
CY2021Q2 evex Finance Cost On Bank Charges
FinanceCostOnBankCharges
0 usd
evex Finance Cost On Bank Charges
FinanceCostOnBankCharges
771 usd
evex Finance Cost On Bank Charges
FinanceCostOnBankCharges
0 usd
CY2022Q2 evex Finance Cost Non Operating
FinanceCostNonOperating
4614 usd
evex Finance Cost Non Operating
FinanceCostNonOperating
26495 usd
evex Finance Cost Non Operating
FinanceCostNonOperating
0 usd
CY2022Q2 evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
810799 usd
evex Monetary And Foreign Exchange Variations On Other Assets
MonetaryAndForeignExchangeVariationsOnOtherAssets
1438 usd
evex Monetary And Foreign Exchange Variations On Other Assets
MonetaryAndForeignExchangeVariationsOnOtherAssets
0 usd
CY2022Q2 evex Financial And Foreign Exchange Gain Loss Net
FinancialAndForeignExchangeGainLossNet
563854 usd
CY2021Q2 evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Trade Accounts Receivable And Contract Assets
MonetaryAndForeignExchangeVariationsOnTradeAccountsReceivableAndContractAssets
-2633 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Trade Accounts Receivable And Contract Assets
MonetaryAndForeignExchangeVariationsOnTradeAccountsReceivableAndContractAssets
0 usd
evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
851960 usd
CY2022Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Cash And Cash Equivalents And Financial Investments
MonetaryAndForeignExchangeVariationsOnCashAndCashEquivalentsAndFinancialInvestments
-371053 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Cash And Cash Equivalents And Financial Investments
MonetaryAndForeignExchangeVariationsOnCashAndCashEquivalentsAndFinancialInvestments
0 usd
evex Monetary And Foreign Exchange Variations On Cash And Cash Equivalents And Financial Investments
MonetaryAndForeignExchangeVariationsOnCashAndCashEquivalentsAndFinancialInvestments
90753 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Taxes And Charges Payable
MonetaryAndForeignExchangeVariationsOnTaxesAndChargesPayable
-8855 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Taxes And Charges Payable
MonetaryAndForeignExchangeVariationsOnTaxesAndChargesPayable
0 usd
evex Monetary And Foreign Exchange Variations On Taxes And Charges Payable
MonetaryAndForeignExchangeVariationsOnTaxesAndChargesPayable
-4513 usd
evex Monetary And Foreign Exchange Variations On Taxes And Charges Payable
MonetaryAndForeignExchangeVariationsOnTaxesAndChargesPayable
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Other Payables
MonetaryAndForeignExchangeVariationsOnOtherPayables
-5900 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Other Payables
MonetaryAndForeignExchangeVariationsOnOtherPayables
46347 usd
evex Monetary And Foreign Exchange Variations On Other Payables
MonetaryAndForeignExchangeVariationsOnOtherPayables
-556 usd
evex Monetary And Foreign Exchange Variations On Other Payables
MonetaryAndForeignExchangeVariationsOnOtherPayables
43873 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Provisions
MonetaryAndForeignExchangeVariationsOnProvisions
-60639 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Provisions
MonetaryAndForeignExchangeVariationsOnProvisions
0 usd
evex Monetary And Foreign Exchange Variations On Provisions
MonetaryAndForeignExchangeVariationsOnProvisions
11674 usd
evex Monetary And Foreign Exchange Variations On Provisions
MonetaryAndForeignExchangeVariationsOnProvisions
0 usd
CY2022Q2 evex Monetary And Foreign Exchange Variations On Liabilities
MonetaryAndForeignExchangeVariationsOnLiabilities
-139597 usd
CY2021Q2 evex Monetary And Foreign Exchange Variations On Liabilities
MonetaryAndForeignExchangeVariationsOnLiabilities
46347 usd
evex Monetary And Foreign Exchange Variations On Liabilities
MonetaryAndForeignExchangeVariationsOnLiabilities
-45022 usd
evex Monetary And Foreign Exchange Variations On Liabilities
MonetaryAndForeignExchangeVariationsOnLiabilities
43873 usd
CY2022Q2 evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
246945 usd
CY2021Q2 evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
46347 usd
evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
-134606 usd
evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
43873 usd
CY2022Q2 evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
810799 usd
CY2021Q2 evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
0 usd
evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
851960 usd
evex Finance Income Cost Non Operating
FinanceIncomeCostNonOperating
0 usd
CY2022Q2 evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
246945 usd
CY2021Q2 evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
46347 usd
evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
-134606 usd
evex Net Monetary And Foreign Exchange Variations
NetMonetaryAndForeignExchangeVariations
43873 usd
CY2021Q2 evex Financial And Foreign Exchange Gain Loss Net
FinancialAndForeignExchangeGainLossNet
-46347 usd
evex Financial And Foreign Exchange Gain Loss Net
FinancialAndForeignExchangeGainLossNet
986566 usd
evex Financial And Foreign Exchange Gain Loss Net
FinancialAndForeignExchangeGainLossNet
-43873 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9835736 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1938812 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18950423 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3830463 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
0 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6475430 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
429467 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7284196 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
757410 usd
evex Expected Dividend As Percentage Shares Granted
ExpectedDividendAsPercentageSharesGranted
0 pure
evex Risk Free Interest Rate Shares Granted
RiskFreeInterestRateSharesGranted
0.0301 pure
CY2021 evex Risk Free Interest Rate Shares Granted
RiskFreeInterestRateSharesGranted
0.0129 pure
evex Expected Term Shares Granted
ExpectedTermSharesGranted
P5Y
CY2021 evex Expected Term Shares Granted
ExpectedTermSharesGranted
P5Y1M6D
evex Expected Volatility Shares Granted
ExpectedVolatilitySharesGranted
0.255 pure
CY2021 evex Expected Volatility Shares Granted
ExpectedVolatilitySharesGranted
0.159 pure
evex Exercise Price Shares Granted
ExercisePriceSharesGranted
11.5
CY2021 evex Exercise Price Shares Granted
ExercisePriceSharesGranted
11.5
evex Expected Dividend As Percentage Shares Granted
ExpectedDividendAsPercentageSharesGranted
0 pure
CY2021 evex Expected Dividend As Percentage Shares Granted
ExpectedDividendAsPercentageSharesGranted
0 pure
evex Expected Stock Price Shares Granted
ExpectedStockPriceSharesGranted
6.2
CY2021 evex Expected Stock Price Shares Granted
ExpectedStockPriceSharesGranted
8.66
evex Probability Weighted Average Of Additional Shares To Be Issued For Forward Contract
ProbabilityWeightedAverageOfAdditionalSharesToBeIssuedForForwardContract
shares
CY2021 evex Probability Weighted Average Of Additional Shares To Be Issued For Forward Contract
ProbabilityWeightedAverageOfAdditionalSharesToBeIssuedForForwardContract
4600000 shares
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0 pure
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
129708 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-11781618 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2414626 usd
us-gaap Net Income Loss
NetIncomeLoss
-4631746 usd
CY2022Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.05
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2022Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
248989790 shares
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220000000 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
234574977 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
220000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17850000 shares
evex Minimum Percentage Of Positive And Negative Variations In Risk Variable
MinimumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.25 pure
evex Maximum Percentage Of Positive And Negative Variations In Risk Variable
MaximumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.50 pure
evex Minimum Percentage Of Positive And Negative Variations In Risk Variable
MinimumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.25 pure
evex Maximum Percentage Of Positive And Negative Variations In Risk Variable
MaximumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.50 pure
evex Minimum Percentage Of Positive And Negative Variations In Risk Variable
MinimumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.25 pure
evex Maximum Percentage Of Positive And Negative Variations In Risk Variable
MaximumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.50 pure
evex Minimum Percentage Of Positive And Negative Variations In Risk Variable
MinimumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.25 pure
evex Maximum Percentage Of Positive And Negative Variations In Risk Variable
MaximumPercentageOfPositiveAndNegativeVariationsInRiskVariable
0.50 pure
CY2021Q3 us-gaap Number Of Properties Subject To Ground Leases
NumberOfPropertiesSubjectToGroundLeases
2 pure
evex Percentage Of Federal And State Net Tax Benefits For Payment Upon Agreement
PercentageOfFederalAndStateNetTaxBenefitsForPaymentUponAgreement
0.75 pure
evex Percentage Of Federal And State Net Tax Benefits For Payment Upon Agreement
PercentageOfFederalAndStateNetTaxBenefitsForPaymentUponAgreement
0.75 pure

Files In Submission

Name View Source Status
0001554855-22-000457-index-headers.html Edgar Link pending
0001554855-22-000457-index.html Edgar Link pending
0001554855-22-000457.txt Edgar Link pending
0001554855-22-000457-xbrl.zip Edgar Link pending
evex-20220630.htm Edgar Link pending
evex-20220630.xsd Edgar Link pending
evex-20220630_cal.xml Edgar Link unprocessable
evex-20220630_def.xml Edgar Link unprocessable
evex-20220630_htm.xml Edgar Link completed
evex-20220630_lab.xml Edgar Link unprocessable
evex-20220630_pre.xml Edgar Link unprocessable
ex311_1.htm Edgar Link pending
ex312_2.htm Edgar Link pending
ex313_3.htm Edgar Link pending
ex321_4.htm Edgar Link pending
ex322_5.htm Edgar Link pending
ex323_6.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending